Solid biosciences reports additional pulmonary function results from the ongoing ignite dmd phase i/ii clinical trial of sgt-001

- improvements in two additional assessments of pulmonary function in treated patients compared with untreated control patients further support potential functional benefit of sgt-001 one-year post administration -

SLDB Ratings Summary

SLDB Quant Ranking